Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 7.2B | 6.4B | 6.9B | 6.6B |
Cost of revenue | 4.3B | 3.7B | 4.5B | 4.1B |
Gross profit | 2.9B | 2.7B | 2.5B | 2.5B |
Operating expense | ||||
Research & development | 281.8M | 264.8M | 329.2M | 268.1M |
Selling general and admin | 1.4B | 1.3B | 1.2B | 1.1B |
Other operating expenses | — | — | — | 60.4M |
Operating income | 1.2B | 1.1B | 915.3M | 1.1B |
Non operating interest income | ||||
Income | 33.0M | 43.5M | 48.3M | 34.6M |
Expense | 12.9M | 37.8M | 6.4M | 33.0M |
Other income expense | — | — | — | — |
Pretax income | 1.3B | 1.3B | 995.8M | 1.1B |
Tax provision | 342.9M | 377.5M | 190.8M | 311.5M |
Net income | 950.7M | 900.0M | 801.0M | 758.3M |
Basic EPS | 0.6 | 0.6 | 0.5 | 0.5 |
Diluted EPS | 0.6 | 0.6 | 0.5 | 0.5 |
Basic average shares | 1.5B | 1.5B | 1.5B | 1.5B |
Diluted average shares | 1.5B | 1.5B | 1.5B | 1.5B |
EBITDA | 1.5B | 1.5B | 1.2B | 1.3B |
Net income from continuing op. | 950.7M | 900.0M | 801.0M | 758.3M |
Minority interests | -24.2M | -12.9M | -6.4M | 4.0M |
Preferred stock dividends | 0 | 0 | 0 | 0 |